Skip to main content
Sisram Medical Ltd logo

Sisram Medical Ltd — Investor Relations & Filings

Ticker · 1696 ISIN · IL0011418113 HKEX Manufacturing
Filings indexed 1,569 across all filing types
Latest filing 2025-09-03 AGM Information
Country HK Hong Kong
Listing HKEX 1696

About Sisram Medical Ltd

http://www.sisram-medical.com

Sisram Medical Ltd. is a global consumer wellness group specializing in medical aesthetics and minimally invasive solutions. Leveraging over two decades of expertise, the company is a leader in Energy-Based Devices (EBD), harnessing natural energy sources for both aesthetic and medical clinical indications. Sisram operates through a synergistic ecosystem of brands, providing medical-grade quality solutions to professional customers and consumers worldwide. Key segments include Alma, a provider of energy-based solutions for surgical and medical aesthetics markets; LMNT, a personal care brand for home use; Copulla, which offers end-to-end digital dentistry services; and a dedicated injectables portfolio. The company's extensive product range covers treatments such as hair removal, skin rejuvenation, body contouring, and dermal fillers.

Recent filings

Filing Released Lang Actions
NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 90% confidence The document is a formal "Notice of Annual General Meeting" published by a Hong Kong‐listed company, detailing the date, location, and resolutions to be voted on (e.g., adoption of financial statements, re‐election of directors, share issuance mandates, amendments to bye‐laws). This clearly falls under AGM Information, specifically materials and notices related to the Annual General Meeting.
2025-09-03 English
(1) PROPOSED AMENDMENTS TO THE EXISTING BYE-LAWS&#x3b; (2) PROPOSED ADOPTION OF SHARE OPTION SCHEME&#x3b; (3) GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES&#x3b; (4) RE-ELECTION OF RETIRING DIRECTOR
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a comprehensive shareholder circular including the notice of the Annual General Meeting (AGM), detailed explanatory statements, proposed resolutions (bye-law amendments, share option scheme, mandates to issue/repurchase shares, re-election of directors), and proxy form instructions. It is distributed to solicit shareholder votes and provide background information ahead of the AGM, matching the definition of a Proxy Solicitation & Information Statement.
2025-09-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025
Regulatory Filings Classification · 87% confidence The document is a monthly return (Form FF301) filed by a listed equity issuer to the Hong Kong Exchanges and Clearing Limited under Chapter 19B of the Listing Rules. It provides detailed periodic information on authorized share capital, issued shares, and other share movements. This is a regulatory listing rule submission rather than an annual/interim report, earnings release, management discussion, or investor presentation. It does not announce a specific share issue or buyback transaction but is a recurring compliance filing. Therefore, the correct classification is Regulatory Filings (RNS).
2025-09-03 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2025
Share Issue/Capital Change Classification · 90% confidence The document is a Hong Kong Stock Exchange (“HKEX”) Listing Rule FF301 monthly return detailing movements in authorised/registered share capital, issued shares, treasury shares and convertibles for Reliance Global Holdings Limited. It is not an earnings release, annual or interim report, nor a voting or management change announcement. Instead, it is a routine regulatory filing on changes in share capital. This fits the definition for Share Issue/Capital Change (SHA).
2025-09-01 English
VOLUNTARY ANNOUNCEMENT
Regulatory Filings Classification · 85% confidence The document is a voluntary announcement by Sisram Medical Ltd introducing a new treatment (PixelPeel™). It is not an earnings release, financial report, board change, capital transaction, or other specific filing. It does not attach or announce publication of a formal report. This type of general corporate and product announcement falls into the fallback category for miscellaneous regulatory announcements. Therefore, it should be classified as a Regulatory Filing (RNS).
2025-08-25 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025
Interim / Quarterly Report Classification · 100% confidence The document is an 'Interim Results Announcement' for Sisram Medical Ltd for the six months ended June 30, 2025. It contains comprehensive unaudited consolidated financial statements, including the statement of profit or loss, statement of comprehensive income, and statement of financial position, along with detailed notes to the financial statements. This meets the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. H2 2025
2025-08-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.